| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.933 | 0.001 | 0.993 | DNA synthesis inhibitor | 0.859 0.002 DBMET03348 0.979 0.001 DBMET01145 0.941 0.001 DBMET00694 0.991 0 DBMET00858 0.993 0 DBMET00859 | DBMET00859 | |
| 0.812 | 0.001 | 0.959 | Antimetabolite | 0.661 0.002 DBMET03348 0.93 0.001 DBMET01145 0.877 0.001 DBMET00694 0.955 0 DBMET00858 0.959 0 DBMET00859 | DBMET00859 | |
| 0.767 | 0.003 | 0.953 | Cytidine deaminase inhibitor | 0.765 0.003 DBMET03348 0.859 0.002 DBMET01145 0.858 0.002 DBMET00694 0.928 0.001 DBMET00858 0.953 0.001 DBMET00859 | DBMET00859 | |
| 0.693 | 0.002 | 0.808 | DNA repair enzyme inhibitor | 0.501 0.002 DBMET03348 0.808 0.001 DBMET01145 0.64 0.002 DBMET00694 0.561 0.002 DBMET00858 0.514 0.002 DBMET00859 | DBMET01145 | |
| 0.676 | 0.005 | 0.676 | DNA damaging | 0.635 0.007 DBMET03348 0.575 0.009 DBMET01145 0.527 0.012 DBMET00694 0.569 0.009 DBMET00858 0.508 0.013 DBMET00859 | ||
| 0.655 | 0.001 | 0.957 | Thymidine kinase inhibitor | 0.779 0.001 DBMET03348 0.879 0.001 DBMET01145 0.938 0 DBMET00694 0.944 0 DBMET00858 0.957 0 DBMET00859 | DBMET00859 | |
| 0.638 | 0.004 | 0.883 | RNA-directed DNA polymerase inhibitor | 0.605 0.005 DBMET03348 0.77 0.002 DBMET01145 0.71 0.002 DBMET00694 0.858 0.001 DBMET00858 0.883 0.001 DBMET00859 | DBMET00859 | |
| 0.553 | 0.001 | 0.821 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.479 0.001 DBMET03348 0.737 0 DBMET01145 0.658 0 DBMET00694 0.802 0 DBMET00858 0.821 0 DBMET00859 | DBMET00859 | |
| 0.553 | 0.002 | 0.779 | Carbamoyl phosphate synthetase inhibitor | 0.195 0.008 DBMET03348 0.731 0 DBMET01145 0.553 0.002 DBMET00694 0.768 0 DBMET00858 0.779 0 DBMET00859 | DBMET00859 | |
| 0.538 | 0.002 | 0.853 | Phosphofructokinase-1 inhibitor | 0.41 0.003 DBMET03348 0.757 0.001 DBMET01145 0.664 0.001 DBMET00694 0.832 0.001 DBMET00858 0.853 0 DBMET00859 | DBMET00859 | |
| 0.524 | 0.002 | 0.935 | Ribonucleotide reductase inhibitor | 0.355 0.003 DBMET03348 0.846 0.001 DBMET01145 0.547 0.002 DBMET00694 0.921 0.001 DBMET00858 0.935 0.001 DBMET00859 | DBMET00859 | |
| 0.52 | 0.002 | 0.832 | Ribonucleoside-diphosphate reductase inhibitor | 0.234 0.005 DBMET03348 0.793 0.001 DBMET01145 0.363 0.003 DBMET00694 0.832 0.001 DBMET00858 0.796 0.001 DBMET00859 | DBMET00858 | |
| 0.513 | 0.002 | 0.735 | UDP-glucose 4-epimerase inhibitor | 0.652 0.001 DBMET03348 0.609 0.001 DBMET01145 0.735 0 DBMET00694 0.644 0.001 DBMET00858 0.654 0.001 DBMET00859 | DBMET00694 | |
| 0.503 | 0.004 | 0.503 | Peptidyltransferase inhibitor | 0.365 0.01 DBMET03348 0.436 0.005 DBMET01145 0.31 0.021 DBMET00694 0.416 0.006 DBMET00858 0.41 0.006 DBMET00859 | ||
| 0.502 | 0.004 | 0.723 | DNA polymerase I inhibitor | 0.349 0.008 DBMET03348 0.596 0.003 DBMET01145 0.539 0.003 DBMET00694 0.694 0.002 DBMET00858 0.723 0.001 DBMET00859 | DBMET00859 | |
| 0.497 | 0.005 | 0.618 | Alkylator | 0.458 0.005 DBMET03348 0.618 0.003 DBMET01145 0.592 0.004 DBMET00694 0.569 0.004 DBMET00858 0.52 0.005 DBMET00859 | DBMET01145 | |
| 0.489 | 0.001 | 0.676 | Phosphoglycerate kinase inhibitor | 0.295 0.002 DBMET03348 0.555 0 DBMET01145 0.481 0.001 DBMET00694 0.621 0 DBMET00858 0.676 0 DBMET00859 | DBMET00859 | |
| 0.539 | 0.063 | 0.539 | Apoptosis agonist | 0.519 0.069 DBMET03348 0.528 0.066 DBMET01145 0.51 0.071 DBMET00694 0.459 0.088 DBMET00858 0.437 0.097 DBMET00859 | ||
| 0.434 | 0.004 | 0.872 | Glutamate dehydrogenase inhibitor | 0.133 0.019 DBMET03348 0.827 0.001 DBMET01145 0.497 0.003 DBMET00694 0.863 0.001 DBMET00858 0.872 0.001 DBMET00859 | DBMET00859 | |
| 0.418 | 0.01 | 0.418 | DNA methylase inhibitor | 0.325 0.021 DBMET03348 0.412 0.01 DBMET01145 0.321 0.022 DBMET00694 0.339 0.019 DBMET00858 0.301 0.028 DBMET00859 | ||
| 0.39 | 0.003 | 0.851 | Argininosuccinate synthase inhibitor | 0.335 0.003 DBMET03348 0.773 0.001 DBMET01145 0.723 0.001 DBMET00694 0.832 0 DBMET00858 0.851 0 DBMET00859 | DBMET00859 | |
| 0.389 | 0.002 | 0.898 | Fumarate hydratase inhibitor | 0.25 0.003 DBMET03348 0.838 0.001 DBMET01145 0.799 0.001 DBMET00694 0.885 0 DBMET00858 0.898 0 DBMET00859 | DBMET00859 | |
| 0.386 | 0.005 | 0.738 | Hexokinase inhibitor | 0.259 0.015 DBMET03348 0.625 0.002 DBMET01145 0.457 0.003 DBMET00694 0.702 0.002 DBMET00858 0.738 0.001 DBMET00859 | DBMET00859 | |
| 0.377 | 0.005 | 0.658 | NADH dehydrogenase inhibitor | 0.333 0.006 DBMET03348 0.591 0.002 DBMET01145 0.565 0.002 DBMET00694 0.658 0.001 DBMET00858 0.636 0.002 DBMET00859 | DBMET00858 | |
| 0.38 | 0.009 | 0.576 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.381 0.009 DBMET03348 0.492 0.004 DBMET01145 0.494 0.004 DBMET00694 0.576 0.003 DBMET00858 0.546 0.003 DBMET00859 | DBMET00858 | |
| 0.376 | 0.008 | 0.673 | Adenylate cyclase inhibitor | 0.305 0.013 DBMET03348 0.616 0.004 DBMET01145 0.539 0.005 DBMET00694 0.661 0.002 DBMET00858 0.673 0.002 DBMET00859 | DBMET00859 | |
| 0.396 | 0.045 | 0.483 | Immunomodulator | 0.428 0.037 DBMET01145 0.227 0.135 DBMET00694 0.483 0.026 DBMET00858 0.454 0.031 DBMET00859 | DBMET00858 | |
| 0.443 | 0.1 | 0.876 | DNA directed DNA polymerase inhibitor | 0.282 0.172 DBMET03348 0.635 0.047 DBMET01145 0.479 0.089 DBMET00694 0.832 0.015 DBMET00858 0.876 0.01 DBMET00859 | DBMET00859 | |
| 0.383 | 0.055 | 0.494 | Immunostimulant | 0.353 0.063 DBMET03348 0.491 0.03 DBMET01145 0.461 0.035 DBMET00694 0.494 0.03 DBMET00858 0.465 0.034 DBMET00859 | DBMET00858 | |
| 0.395 | 0.079 | 0.432 | Antibacterial | 0.432 0.063 DBMET03348 0.365 0.094 DBMET01145 0.405 0.075 DBMET00694 0.326 0.116 DBMET00858 0.279 0.151 DBMET00859 | DBMET03348 | |
| 0.319 | 0.02 | 0.319 | DNA methyltransferase I inhibitor | 0.285 0.032 DBMET03348 | ||
| 0.272 | 0.005 | 0.842 | Ornithine carbamoyltransferase inhibitor | 0.177 0.008 DBMET03348 0.756 0.001 DBMET01145 0.614 0.002 DBMET00694 0.824 0.001 DBMET00858 0.842 0.001 DBMET00859 | DBMET00859 | |
| 0.241 | 0.011 | 0.508 | Adenylate kinase inhibitor | 0.164 0.022 DBMET03348 0.455 0.002 DBMET01145 0.403 0.003 DBMET00694 0.495 0.001 DBMET00858 0.508 0.001 DBMET00859 | DBMET00859 | |
| 0.238 | 0.011 | 0.72 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.588 0.002 DBMET03348 0.475 0.003 DBMET01145 0.72 0.001 DBMET00694 0.501 0.003 DBMET00858 0.475 0.003 DBMET00859 | DBMET00694 | |
| 0.219 | 0.011 | 0.538 | DNA directed RNA polymerase inhibitor | 0.29 0.007 DBMET03348 0.341 0.005 DBMET01145 0.407 0.005 DBMET00694 0.489 0.004 DBMET00858 0.538 0.004 DBMET00859 | DBMET00859 | |
| 0.211 | 0.008 | 0.251 | Transcription factor NF kappa B stimulant | 0.118 0.026 DBMET03348 0.212 0.008 DBMET01145 0.13 0.021 DBMET00694 0.251 0.006 DBMET00858 0.243 0.006 DBMET00859 | DBMET00858 | |
| 0.202 | 0.013 | 0.399 | Mucolytic | 0.204 0.012 DBMET03348 0.235 0.008 DBMET01145 0.237 0.008 DBMET00694 0.362 0.003 DBMET00858 0.399 0.003 DBMET00859 | DBMET00859 | |
| 0.19 | 0.012 | 0.19 | Adenosine A1 receptor antagonist | 0.085 0.027 DBMET03348 | ||
| 0.271 | 0.097 | 0.303 | Interleukin 2 agonist | 0.303 0.072 DBMET03348 | DBMET03348 | |
| 0.184 | 0.011 | 0.184 | Adenosine A2a receptor antagonist | 0.074 0.034 DBMET03348 | ||
| 0.192 | 0.022 | 0.489 | Expectorant | 0.188 0.023 DBMET03348 0.269 0.011 DBMET01145 0.264 0.011 DBMET00694 0.448 0.004 DBMET00858 0.489 0.004 DBMET00859 | DBMET00859 | |
| 0.178 | 0.013 | 0.527 | Aminoacyl-tRNA synthetase inhibitor | 0.14 0.022 DBMET03348 0.364 0.004 DBMET01145 0.341 0.005 DBMET00694 0.478 0.003 DBMET00858 0.527 0.003 DBMET00859 | DBMET00859 | |
| 0.166 | 0.004 | 0.79 | HCV NS5B polymerase inhibitor | 0.239 0.003 DBMET03348 0.472 0.002 DBMET01145 0.549 0.002 DBMET00694 0.738 0.001 DBMET00858 0.79 0.001 DBMET00859 | DBMET00859 | |
| 0.169 | 0.008 | 0.468 | Biliverdin reductase inhibitor | 0.199 0.006 DBMET03348 0.437 0.002 DBMET01145 0.468 0.001 DBMET00694 0.46 0.001 DBMET00858 0.437 0.002 DBMET00859 | DBMET00694 | |
| 0.318 | 0.174 | 0.727 | Caspase 9 stimulant | 0.48 0.068 DBMET03348 0.488 0.065 DBMET01145 0.727 0.021 DBMET00694 0.286 0.209 DBMET00858 | DBMET00694 | |
| 0.158 | 0.015 | 0.158 | Adenosine A2 receptor antagonist | 0.065 0.043 DBMET03348 | ||
| 0.254 | 0.13 | 0.302 | Vasodilator, coronary | 0.211 0.172 DBMET03348 0.279 0.106 DBMET00858 0.302 0.086 DBMET00859 | DBMET00859 | |
| 0.165 | 0.047 | 0.254 | Alpha-N-acetylglucosaminidase inhibitor | 0.254 0.022 DBMET03348 | DBMET03348 | |
| 0.124 | 0.01 | 0.494 | Phosphorylase inhibitor | 0.243 0.004 DBMET03348 0.253 0.004 DBMET01145 0.494 0.002 DBMET00694 0.384 0.003 DBMET00858 0.412 0.003 DBMET00859 | DBMET00694 | |
| 0.162 | 0.054 | 0.163 | Cell wall synthesis inhibitor | 0.147 0.069 DBMET03348 0.163 0.054 DBMET01145 0.147 0.068 DBMET00694 0.162 0.054 DBMET00858 0.137 0.078 DBMET00859 | DBMET01145 | |
| 0.124 | 0.021 | 0.412 | HIV-1 reverse transcriptase inhibitor | 0.166 0.012 DBMET03348 0.202 0.009 DBMET01145 0.254 0.007 DBMET00694 0.36 0.005 DBMET00858 0.412 0.004 DBMET00859 | DBMET00859 | |
| 0.179 | 0.081 | 0.2 | Hepatoprotectant | 0.2 0.065 DBMET03348 0.147 0.113 DBMET00694 0.133 0.13 DBMET00859 | DBMET03348 | |
| 0.16 | 0.063 | 0.198 | NOS3 expression enhancer | 0.198 0.042 DBMET03348 | DBMET03348 | |
| 0.098 | 0.003 | 0.218 | Thymidine phosphorylase inhibitor | 0.218 0.002 DBMET03348 0.075 0.004 DBMET01145 0.159 0.002 DBMET00694 0.044 0.005 DBMET00858 0.038 0.007 DBMET00859 | DBMET03348 | |
| 0.115 | 0.02 | 0.115 | Adenosine A3 receptor antagonist | 0.083 0.039 DBMET03348 | ||
| 0.098 | 0.006 | 0.102 | Adenosine deaminase inhibitor | 0.076 0.01 DBMET03348 0.091 0.007 DBMET01145 0.071 0.013 DBMET00694 0.102 0.005 DBMET00858 0.096 0.006 DBMET00859 | DBMET00858 | |
| 0.098 | 0.017 | 0.264 | Acyl-CoA dehydrogenase inhibitor | 0.062 0.031 DBMET03348 0.236 0.003 DBMET01145 0.197 0.005 DBMET00694 0.264 0.002 DBMET00858 0.255 0.003 DBMET00859 | DBMET00858 | |
| 0.082 | 0.004 | 0.165 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.079 0.004 DBMET03348 0.133 0.001 DBMET01145 0.129 0.001 DBMET00694 0.156 0.001 DBMET00858 0.165 0.001 DBMET00859 | DBMET00859 | |
| 0.082 | 0.007 | 0.192 | Thymidylate synthase inhibitor | 0.082 0.007 DBMET03348 0.192 0.002 DBMET01145 0.19 0.002 DBMET00694 0.101 0.004 DBMET00858 0.09 0.005 DBMET00859 | DBMET01145 | |
| 0.076 | 0.004 | 0.414 | Uridine phosphorylase inhibitor | 0.301 0.001 DBMET03348 0.094 0.003 DBMET01145 0.414 0.001 DBMET00694 0.065 0.005 DBMET00858 0.058 0.006 DBMET00859 | DBMET00694 | |
| 0.068 | 0.005 | 0.091 | Guanylate cyclase inhibitor | 0.054 0.017 DBMET03348 0.084 0.002 DBMET01145 0.077 0.003 DBMET00694 0.09 0.002 DBMET00858 0.091 0.001 DBMET00859 | DBMET00859 | |
| 0.079 | 0.025 | 0.273 | Purinergic P2X1 antagonist | 0.218 0.003 DBMET01145 0.172 0.005 DBMET00694 0.258 0.002 DBMET00858 0.273 0.002 DBMET00859 | DBMET00859 | |
| 0.137 | 0.086 | 0.137 | Adenylate cyclase stimulant | 0.128 0.105 DBMET03348 0.134 0.092 DBMET01145 0.125 0.112 DBMET00694 | ||
| 0.053 | 0.003 | 0.185 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.185 0.002 DBMET03348 0.049 0.004 DBMET01145 0.159 0.002 DBMET00694 0.032 0.009 DBMET00858 0.03 0.011 DBMET00859 | DBMET03348 | |
| 0.056 | 0.01 | 0.056 | Antibiotic Aminoglycoside-like | 0.055 0.011 DBMET03348 0.045 0.017 DBMET01145 0.044 0.018 DBMET00694 0.042 0.019 DBMET00858 0.041 0.02 DBMET00859 | ||
| 0.136 | 0.093 | 0.395 | Heat shock protein 70 antagonist | 0.201 0.006 DBMET01145 0.172 0.016 DBMET00694 0.351 0.003 DBMET00858 0.395 0.003 DBMET00859 | DBMET00859 | |
| 0.159 | 0.117 | 0.159 | Angiogenesis stimulant | 0.158 0.117 DBMET03348 | ||
| 0.123 | 0.081 | 0.123 | Interleukin 4 antagonist | |||
| 0.041 | 0.003 | 0.041 | Isoleucine-tRNA ligase inhibitor | 0.031 0.005 DBMET03348 0.023 0.014 DBMET01145 | ||
| 0.071 | 0.033 | 0.071 | Interferon inducer | |||
| 0.062 | 0.025 | 0.106 | Adenine nucleotide translocase inhibitor | 0.104 0.004 DBMET03348 0.068 0.017 DBMET01145 0.106 0.004 DBMET00694 0.063 0.024 DBMET00858 0.061 0.026 DBMET00859 | DBMET00694 | |
| 0.043 | 0.007 | 0.114 | Adenosine kinase inhibitor | 0.024 0.013 DBMET03348 0.073 0.004 DBMET01145 0.036 0.008 DBMET00694 0.102 0.003 DBMET00858 0.114 0.003 DBMET00859 | DBMET00859 | |
| 0.043 | 0.007 | 0.043 | Adenosine A1 receptor agonist | 0.037 0.008 DBMET03348 0.038 0.008 DBMET01145 0.033 0.01 DBMET00694 0.033 0.01 DBMET00858 0.032 0.01 DBMET00859 | ||
| 0.054 | 0.018 | 0.147 | AICAR transformylase inhibitor | 0.062 0.013 DBMET03348 0.13 0.004 DBMET01145 0.147 0.003 DBMET00694 0.075 0.008 DBMET00858 0.067 0.011 DBMET00859 | DBMET00694 | |
| 0.164 | 0.13 | 0.302 | Cyclic AMP phosphodiesterase inhibitor | 0.302 0.041 DBMET03348 | DBMET03348 | |
| 0.062 | 0.028 | 0.065 | Glucosylceramidase inhibitor | 0.065 0.026 DBMET03348 | DBMET03348 | |
| 0.082 | 0.05 | 0.082 | Interferon agonist | |||
| 0.034 | 0.004 | 0.08 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.08 0.002 DBMET03348 0.022 0.012 DBMET00694 | DBMET03348 | |
| 0.041 | 0.015 | 0.041 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 DBMET00858 0.033 0.03 DBMET00859 | ||
| 0.041 | 0.015 | 0.198 | Purinergic P2Y2 antagonist | 0.09 0.004 DBMET03348 0.14 0.003 DBMET01145 0.177 0.002 DBMET00694 0.187 0.002 DBMET00858 0.198 0.002 DBMET00859 | DBMET00859 | |
| 0.03 | 0.005 | 0.355 | Purinergic receptor agonist | 0.046 0.003 DBMET03348 0.093 0.001 DBMET01145 0.116 0.001 DBMET00694 0.248 0.001 DBMET00858 0.355 0.001 DBMET00859 | DBMET00859 | |
| 0.03 | 0.005 | 0.355 | Purinergic P2 agonist | 0.046 0.003 DBMET03348 0.093 0.001 DBMET01145 0.116 0.001 DBMET00694 0.248 0.001 DBMET00858 0.355 0.001 DBMET00859 | DBMET00859 | |
| 0.041 | 0.018 | 0.462 | RNA-directed RNA polymerase inhibitor | 0.076 0.007 DBMET03348 0.118 0.004 DBMET01145 0.24 0.003 DBMET00694 0.396 0.003 DBMET00858 0.462 0.002 DBMET00859 | DBMET00859 | |
| 0.024 | 0.001 | 0.217 | Purinergic P2Y2 agonist | 0.028 0.001 DBMET03348 0.083 0 DBMET01145 0.123 0 DBMET00694 0.171 0 DBMET00858 0.217 0 DBMET00859 | DBMET00859 | |
| 0.029 | 0.006 | 0.029 | Adenosine A2a receptor agonist | |||
| 0.028 | 0.005 | 0.028 | Adenosine A2 receptor agonist | |||
| 0.035 | 0.015 | 0.259 | Purinergic P2X agonist | 0.028 0.019 DBMET03348 0.116 0.003 DBMET01145 0.108 0.003 DBMET00694 0.205 0.002 DBMET00858 0.259 0.001 DBMET00859 | DBMET00859 | |
| 0.095 | 0.074 | 0.104 | Topoisomerase I inhibitor | 0.104 0.067 DBMET03348 | DBMET03348 | |
| 0.024 | 0.004 | 0.336 | Purinergic P2Y agonist | 0.04 0.003 DBMET03348 0.083 0.001 DBMET01145 0.108 0.001 DBMET00694 0.225 0.001 DBMET00858 0.336 0.001 DBMET00859 | DBMET00859 | |
| 0.046 | 0.027 | 0.119 | Geranyltranstransferase inhibitor | 0.077 0.005 DBMET01145 0.056 0.017 DBMET00694 0.119 0.003 DBMET00858 0.108 0.003 DBMET00859 | DBMET00858 | |
| 0.194 | 0.178 | 0.194 | Caspase 3 stimulant | |||
| 0.02 | 0.006 | 0.119 | Purinergic P2Y1 agonist | 0.021 0.006 DBMET03348 0.072 0.001 DBMET01145 0.075 0.001 DBMET00694 0.106 0.001 DBMET00858 0.119 0.001 DBMET00859 | DBMET00859 | |
| 0.019 | 0.006 | 0.019 | Adenosine A2b receptor agonist | 0.015 0.01 DBMET03348 0.013 0.012 DBMET01145 | ||
| 0.02 | 0.008 | 0.02 | Adenosine A3 receptor agonist | 0.019 0.01 DBMET03348 | ||
| 0.019 | 0.007 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.015 0.01 DBMET03348 0.014 0.012 DBMET01145 | ||
| 0.028 | 0.02 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.019 | 0.011 | 0.033 | Methylmalonyl-CoA mutase inhibitor | 0.029 0.003 DBMET01145 0.025 0.004 DBMET00694 0.033 0.002 DBMET00858 0.031 0.002 DBMET00859 | DBMET00858 | |
| 0.042 | 0.036 | 0.044 | Mannosidase inhibitor | 0.044 0.033 DBMET03348 | DBMET03348 | |
| 0.007 | 0.001 | 0.081 | Purinergic P2Y6 agonist | 0.011 0.001 DBMET03348 0.029 0 DBMET01145 0.073 0 DBMET00694 0.063 0 DBMET00858 0.081 0 DBMET00859 | DBMET00859 | |
| 0.201 | 0.196 | 0.456 | Immunosuppressant | 0.247 0.15 DBMET03348 0.424 0.055 DBMET01145 0.456 0.045 DBMET00694 0.325 0.1 DBMET00858 0.314 0.107 DBMET00859 | DBMET00694 | |
| 0.047 | 0.044 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 DBMET01145 | DBMET01145 | |
| 0.044 | 0.041 | 0.087 | Glucose-6-phosphate isomerase inhibitor | 0.049 0.031 DBMET03348 0.078 0.009 DBMET01145 0.087 0.007 DBMET00694 0.054 0.024 DBMET00858 0.05 0.029 DBMET00859 | DBMET00694 | |
| 0.012 | 0.008 | 0.018 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET03348 0.014 0.005 DBMET01145 0.015 0.005 DBMET00694 0.018 0.004 DBMET00858 0.016 0.004 DBMET00859 | DBMET00858 | |
| 0.025 | 0.022 | 0.028 | Sodium/glucose cotransporter 2 inhibitor | 0.028 0.016 DBMET03348 | DBMET03348 | |
| 0.048 | 0.047 | 0.055 | Alpha-mannosidase inhibitor | 0.055 0.034 DBMET03348 | DBMET03348 | |
| 0.018 | 0.016 | 0.079 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.062 0.004 DBMET01145 0.06 0.004 DBMET00694 0.079 0.003 DBMET00858 0.076 0.003 DBMET00859 | DBMET00858 | |
| 0.004 | 0.003 | 0.136 | Purinergic P2Y4 agonist | 0.007 0.002 DBMET03348 0.015 0.001 DBMET01145 0.022 0.001 DBMET00694 0.064 0.001 DBMET00858 0.136 0 DBMET00859 | DBMET00859 | |
| 0.024 | 0.023 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 DBMET03348 | DBMET03348 | |
| 0.051 | 0.052 | 0.12 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.105 0.015 DBMET01145 0.12 0.012 DBMET00858 0.102 0.016 DBMET00859 | DBMET00858 | |
| 0.017 | 0.018 | 0.306 | Purinergic P2T antagonist | 0.091 0.005 DBMET01145 0.09 0.005 DBMET00694 0.228 0.004 DBMET00858 0.306 0.003 DBMET00859 | DBMET00859 | |
| 0.037 | 0.041 | 0.411 | Purinergic P2Y antagonist | 0.058 0.02 DBMET03348 0.273 0.003 DBMET01145 0.337 0.003 DBMET00694 0.376 0.003 DBMET00858 0.411 0.002 DBMET00859 | DBMET00859 | |
| 0.053 | 0.057 | 0.276 | Purinergic P2X2 antagonist | 0.213 0.004 DBMET01145 0.19 0.005 DBMET00694 0.256 0.003 DBMET00858 0.276 0.002 DBMET00859 | DBMET00859 | |
| 0.019 | 0.025 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 DBMET01145 | DBMET01145 | |
| 0.173 | 0.191 | 0.226 | Cholesterol antagonist | 0.226 0.143 DBMET03348 | DBMET03348 | |
| 0.101 | 0.119 | 0.119 | Protein kinase stimulant | 0.119 0.094 DBMET03348 0.109 0.107 DBMET00694 | DBMET03348 | |
| 0.014 | 0.034 | 0.218 | Purinergic P2Y12 antagonist | 0.069 0.005 DBMET01145 0.076 0.005 DBMET00694 0.152 0.004 DBMET00858 0.218 0.004 DBMET00859 | DBMET00859 | |
| 0.072 | 0.095 | 0.23 | Triose-phosphate isomerase inhibitor | 0.095 0.053 DBMET03348 0.161 0.017 DBMET01145 0.23 0.008 DBMET00694 0.093 0.055 DBMET00858 0.084 0.068 DBMET00859 | DBMET00694 | |
| 0.041 | 0.067 | 0.144 | Antiviral (Hepatitis D) | 0.079 0.009 DBMET01145 0.063 0.019 DBMET00694 0.125 0.004 DBMET00858 0.144 0.003 DBMET00859 | DBMET00859 | |
| 0.071 | 0.105 | 0.082 | Uric acid excretion stimulant | 0.082 0.08 DBMET03348 | DBMET03348 | |
| 0.118 | 0.153 | 0.166 | Interleukin 6 antagonist | 0.166 0.068 DBMET03348 0.164 0.071 DBMET00694 | DBMET03348 | |
| 0.139 | 0.177 | 0.178 | Interleukin agonist | 0.178 0.141 DBMET03348 | DBMET03348 | |
| 0.165 | 0.22 | 0.327 | Vasodilator, peripheral | 0.314 0.09 DBMET03348 0.245 0.13 DBMET00694 0.277 0.109 DBMET00858 0.327 0.084 DBMET00859 | DBMET00859 | |
| 0.031 | 0.094 | 0.088 | HIV-1 integrase (Strand Transfer) inhibitor | 0.088 0.027 DBMET01145 0.08 0.031 DBMET00694 | DBMET01145 | |
| 0.007 | 0.072 | 0.073 | Purinergic P2Y1 antagonist | 0.062 0.003 DBMET01145 0.061 0.003 DBMET00694 0.068 0.003 DBMET00858 0.073 0.003 DBMET00859 | DBMET00859 | |
| 0.078 | 0.149 | 0.345 | Aldehyde dehydrogenase inhibitor | 0.234 0.021 DBMET01145 0.294 0.012 DBMET00694 0.345 0.008 DBMET00858 0.303 0.011 DBMET00859 | DBMET00858 | |
| 0.037 | 0.108 | 0.086 | HIV-1 integrase (3'-Processing) inhibitor | 0.086 0.031 DBMET01145 0.073 0.037 DBMET00694 | DBMET01145 | |
| 0.125 | 0.198 | 0.244 | Vasodilator | 0.183 0.119 DBMET03348 0.168 0.134 DBMET01145 0.226 0.085 DBMET00694 0.226 0.085 DBMET00858 0.244 0.072 DBMET00859 | DBMET00859 | |
| 0.032 | 0.115 | 0.15 | Carbonic anhydrase V inhibitor | 0.077 0.038 DBMET03348 0.061 0.053 DBMET01145 0.15 0.014 DBMET00694 | DBMET00694 | |
| 0.035 | 0.123 | 0.075 | Carbonic anhydrase VA inhibitor | 0.075 0.04 DBMET03348 0.072 0.043 DBMET00694 | DBMET03348 | |
| 0.053 | 0.165 | 0.228 | Phosphodiesterase I inhibitor | 0.116 0.03 DBMET01145 0.183 0.012 DBMET00694 0.202 0.01 DBMET00858 0.228 0.008 DBMET00859 | DBMET00859 | |
| 0.056 | 0.17 | 0.145 | Anabolic | 0.103 0.059 DBMET03348 0.096 0.069 DBMET01145 0.145 0.021 DBMET00694 0.113 0.046 DBMET00858 0.12 0.039 DBMET00859 | DBMET00694 | |
| 0.014 | 0.132 | 0.082 | Inosine monophosphate dehydrogenase inhibitor | 0.067 0.009 DBMET01145 0.081 0.006 DBMET00694 0.082 0.006 DBMET00858 0.064 0.009 DBMET00859 | DBMET00858 | |
| 0.014 | 0.14 | 0.069 | Carbonic anhydrase VB inhibitor | 0.069 0.028 DBMET03348 | DBMET03348 | |
| 0.057 | 0.186 | 0.156 | AMP-activated protein kinase stimulant | 0.156 0.024 DBMET03348 0.111 0.057 DBMET00694 | DBMET03348 | |
| 0.001 | 0.143 | 0.016 | Mannitol 2-dehydrogenase inhibitor | 0.015 0.003 DBMET01145 0.016 0.003 DBMET00694 0.008 0.006 DBMET00858 0.008 0.006 DBMET00859 | DBMET00694 | |
| 0.061 | 0.205 | 0.093 | Phosphodiesterase 6D inhibitor | 0.093 0.066 DBMET03348 | DBMET03348 | |
| 0.005 | 0.154 | 0.035 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.027 0.009 DBMET01145 0.025 0.01 DBMET00694 0.035 0.006 DBMET00858 0.026 0.009 DBMET00859 | DBMET00858 | |
| 0.057 | 0.212 | 0.09 | Hematopoietic | 0.082 0.068 DBMET01145 0.09 0.049 DBMET00694 | DBMET00694 | |
| 0.016 | 0.172 | 0.04 | Toll-Like receptor 4 agonist | 0.036 0.007 DBMET01145 0.04 0.005 DBMET00694 0.03 0.011 DBMET00858 0.029 0.012 DBMET00859 | DBMET00694 | |
| 0.127 | 0.29 | 0.307 | Antithrombotic | 0.248 0.128 DBMET01145 0.307 0.083 DBMET00694 0.207 0.169 DBMET00858 | DBMET00694 | |
| 0.036 | 0.205 | 0.103 | Alcohol dehydrogenase inhibitor | 0.087 0.068 DBMET01145 0.099 0.053 DBMET00694 0.103 0.049 DBMET00858 0.088 0.067 DBMET00859 | DBMET00858 | |
| 0.062 | 0.249 | 0.121 | Acetylcholine M1 receptor antagonist | 0.121 0.107 DBMET00859 | DBMET00859 | |
| 0.093 | 0.282 | 0.233 | Phospholipase C inhibitor | 0.233 0.029 DBMET01145 0.223 0.032 DBMET00694 0.153 0.101 DBMET00858 0.141 0.127 DBMET00859 | DBMET01145 | |
| 0.021 | 0.218 | 0.171 | Purinergic P2X4 antagonist | 0.076 0.008 DBMET01145 0.13 0.004 DBMET00694 0.137 0.004 DBMET00858 0.171 0.004 DBMET00859 | DBMET00859 | |
| 0.069 | 0.272 | 0.212 | Antimitotic | 0.212 0.077 DBMET01145 0.194 0.088 DBMET00694 | DBMET01145 | |
| 0.01 | 0.236 | 0.026 | Integrin alpha2beta1 antagonist | 0.026 0.018 DBMET03348 | DBMET03348 | |
| 0.047 | 0.28 | 0.102 | Toll-Like receptor 4 antagonist | 0.099 0.071 DBMET01145 0.102 0.066 DBMET00694 | DBMET00694 | |
| 0.057 | 0.294 | 0.272 | Anesthetic general | 0.15 0.113 DBMET03348 0.272 0.041 DBMET00694 | DBMET00694 | |
| 0.019 | 0.295 | 0.083 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.073 0.058 DBMET00694 0.083 0.049 DBMET00858 0.07 0.061 DBMET00859 | DBMET00858 | |
| 0.013 | 0.309 | 0.304 | Purinergic P2 antagonist | 0.177 0.008 DBMET01145 0.237 0.005 DBMET00694 0.269 0.005 DBMET00858 0.304 0.005 DBMET00859 | DBMET00859 | |
| 0.045 | 0.36 | 0.17 | Mannose-6-phosphate isomerase inhibitor | 0.15 0.065 DBMET01145 0.17 0.049 DBMET00694 | DBMET00694 | |
| 0.028 | 0.373 | 0.161 | Psychostimulant | 0.161 0.107 DBMET01145 0.159 0.109 DBMET00694 0.137 0.129 DBMET00858 | DBMET01145 | |
| 0.049 | 0.417 | 0.135 | Insulin secretagoues | 0.12 0.111 DBMET00858 0.135 0.091 DBMET00859 | DBMET00859 | |
| 0.047 | 0.437 | 0.093 | Folate antagonist | 0.093 0.079 DBMET01145 | DBMET01145 | |
| 0.038 | 0.429 | 0.177 | Platelet antagonist | 0.158 0.136 DBMET00694 0.161 0.133 DBMET00858 0.177 0.119 DBMET00859 | DBMET00859 | |
| 0.023 | 0.474 | 0.352 | Pyruvate kinase inhibitor | 0.191 0.086 DBMET01145 0.171 0.099 DBMET00694 0.315 0.044 DBMET00858 0.352 0.033 DBMET00859 | DBMET00859 | |
| 0.004 | 0.618 | 0.036 | Purinergic P2X3 antagonist | 0.036 0.021 DBMET00859 | DBMET00859 | |
| 0.042 | 0.746 | 0.167 | Sphingosine 1-phosphate receptor 2 agonist | 0.167 0.018 DBMET01145 0.153 0.024 DBMET00694 0.102 0.096 DBMET00858 | DBMET01145 | |
| 0.008 | 0.72 | 0.04 | Nicotinic acid receptor 1 agonist | 0.04 0.028 DBMET03348 | DBMET03348 | |
| 0.004 | 0.775 | 0.035 | Growth factor receptor-bound protein 2 antagonist | 0.034 0.026 DBMET01145 0.035 0.024 DBMET00694 0.032 0.031 DBMET00858 | DBMET00694 | |
| 0.008 | 0.845 | 0.06 | Autotaxin inhibitor | 0.06 0.029 DBMET00694 | DBMET00694 | |
| 0.007 | 0.905 | 0.11 | Bone formation stimulant | 0.11 0.095 DBMET01145 0.108 0.097 DBMET00694 | DBMET01145 | |
| 0.004 | 0.906 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.037 DBMET01145 0.053 0.038 DBMET00694 | DBMET01145 | |
| 0.002 | 0.943 | 0.064 | Sphingosine 1-phosphate receptor 3 agonist | 0.061 0.012 DBMET01145 0.064 0.011 DBMET00694 | DBMET00694 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |